Home » Topics » BioWorld Science

BioWorld Science
RSS

Colloral dose refinement study underway

March 15, 1996

Lilly reports drugs for osteoarthritis

March 15, 1996

Glaxo Wellcome formalizes development status of arthritis drug

March 15, 1996

U.S. phase III trials of Remune begin

March 15, 1996

Nitazoxanide advances in phase II

March 15, 1996

Neupogen approved for AIDS-related indication

March 15, 1996

Alpha Leukoferon to be tested in HIV-infected hemophiliacs

March 15, 1996

Cidofovir approval recommended by committee

March 15, 1996

MDX-240 promising in HIV trials

March 15, 1996

Nagrestip tested for use in HIV

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 17, 2025
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...